Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Checkpoint inhibitors set to face off in bladder cancer
Checkpoint inhibitors set to face off in bladder cancer
Checkpoint inhibitors set to face off in bladder cancer
Submitted by
admin
on February 8, 2017 - 9:48am
Source:
BioPharma Dive
News Tags:
bladder cancer
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
Roche
Tecentriq
AstraZeneca
durvalumab
Headline:
Checkpoint inhibitors set to face off in bladder cancer
Do Not Allow Advertisers to Use My Personal information
